SINGULAR GENOMICS SYSTEMS IN (OMIC)
US82933R1005 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 24.11M | 16.23M | 74.30M | 201.00M | 11.70M | |||
| Marketable Securities | 126.99M | 159.17M | 170.90M | 138.90M | 15.20M | |||
| Receivables | 137.00K | 565.00K | 900.00K | N/A | N/A | |||
| Inventories | 13.08M | 13.57M | 18.20M | 3.00M | N/A | |||
| Other Current Assets | 2.16M | 2.69M | 4.10M | 4.80M | 700.00K | |||
| Total Current Assets | 166.47M | 192.23M | 268.40M | 347.80M | 27.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 70.95M | 71.49M | 56.70M | 6.10M | 2.40M | |||
| Other Non-Current Assets | 1.68M | 1.75M | 2.90M | 1.80M | 600.00K | |||
| Total Non-Current Assets | 72.63M | 73.24M | 59.60M | 7.80M | 2.90M | |||
| TOTAL ASSETS | 239.10M | 265.47M | 328.00M | 355.60M | 30.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.63M | N/A | N/A | 0.00 | 900.00K | |||
| Accrued Expenses | 11.09M | 13.84M | 10.90M | 4.30M | 1.60M | |||
| Accounts Payable | 2.01M | 2.59M | 3.10M | 2.30M | 400.00K | |||
| Other Current Liabilities | 355.00K | 1.86M | 100.00K | 100.00K | 700.00K | |||
| Total Current Liabilities | 16.08M | 18.29M | 14.10M | 6.70M | 3.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 7.63M | 8.90M | 10.10M | 9.90M | 8.50M | |||
| Other Non-Current Liabilities | 58.70M | 59.27M | 43.50M | 2.80M | 700.00K | |||
| Total Non-Current Liabilities | 66.32M | 68.17M | 53.60M | 12.80M | 9.20M | |||
| TOTAL LIABILITIES | 82.40M | 86.46M | 67.70M | 19.50M | 12.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -362.62M | -337.60M | -242.80M | -151.90M | -53.10M | |||
| Additional Paid In Capital | 519.36M | 516.44M | 503.90M | 488.20M | 1.60M | |||
| Common Shares | 7.00K | 7.00K | 0.00 | 0.00 | 69.20M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | -140.00K | N/A | |||
| Shares Outstanding | 74.07M | 73.82M | 71.90M | 72.40M | 69.40M | |||
| Tangible Book Value per Share | 2.12 | 2.42 | 3.62 | 4.64 | -0.74 | |||
| Total Shareholders' Equity | 156.70M | 179.01M | 260.30M | 336.20M | 17.60M | |||
| TOTAL LIABILITIES AND EQUITY | 239.10M | 265.47M | 328.00M | 355.60M | 30.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.05 | 0.04 | 0.03 | 0.48 | |||
| Current Ratio | 10.35 | 10.51 | 19.04 | 51.91 | 7.46 | |||
| Return On Assets (ROA) | -40.24% | -35.72% | -27.71% | -27.78% | -91.64% | |||
| Return On Equity (ROE) | -61.40% | -52.97% | -34.91% | -29.38% | -158.81% | |||
All data in USD